AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
SKWD

Skyward Specialty Insurance Group Inc. Common Stock (SKWD) fair value

Financial Services · Insurance - Property & Casualty · NASDAQ · United States
$60.39-2.85%
Market cap $2.7BNext earnings 2026-11-05Updated Oct 19, 2026
Add earnings to calendarGoogle
Our verdict
Trades 7% above our fair value
Price
$60.39
Model fair valueConfidence: good
$56.63
Model range
$53.87 to $59.86
Fair value $56.63
Price $60.39
2 models fit Skyward Specialty Insurance Group Inc. Common Stock and they agree: 2 of 2 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Near fair value(i)Silver71
Valued as an insurer: Residual income and P/E comparison.
ACCE opinionSkyward Specialty Insurance Group Inc. Common Stock (SKWD)
Fair value (2 models)
$56.63
ACCE price target
$64.00
Rating
Fairly valued
Horizon
12 months
Fair value published on 19 Oct 2026, 18:04 CEST; previously $55.74 since 10 Oct 2026, 00:00 CEST.
ACCE price target published on 11 Oct 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 18:04 CEST.
Price used: $60.39 at the close on 23 Oct 2026, 22:00 CEST.
Models: P/E comparison and Residual income.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
6.6% above
-6.2% to fair value
ACCE score
82
out of 100
Analysts
69% buy
13 covering
P/E
14.0x
forward 11.5x
1-year return
+29.6%
Dividend yield
0.00%

Skyward Specialty Insurance Group Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Skyward Specialty writes excess and surplus lines property and casualty insurance, placing hard-to-place commercial risks such as small-business liability, professional lines and property coverage that standard carriers decline. Its edge is underwriting discipline in a niche where specialist pricing and binding authority give it room to pick its own risks rather than chase premium volume. Revenue growth of 53% is the headline, and with a forward P/E of 9.9 against a trailing 14.2, the market is pricing in earnings expansion that has yet to show up in reported results. Return on equity of 17.3% with a 14.8% operating margin suggests the growth is coming with returns, not at their expense. The 2.7 billion dollar market cap and absence from major indices mean coverage is thin, which is where a deeper look is most likely to turn up something the screen has missed.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 1 flagAI-assisted·How I use AI
  • moderate
    Insider selling outweighs buying
    Insiders disclosed $0.47M in sales against $0.09M in buys across the last 10 filings, a net-selling tilt worth watching alongside the stock trading 6.6% above $56.63 model fair value.

AI research notes

AI-assisted·How I use AIWritten Oct 20, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 53.0% year over year, well above its 25.8% average annual pace over five years.
  • Free cash flow over the last twelve months reached $403M, a 14.8% yield at the current share price.
Why it could disappoint
  • The stock trades 6.6% above the model fair value of $56.63, so the consensus models do not support the price.
  • Rapid premium growth of 53% may strain underwriting, and specialty casualty reserve development is a high-level risk on file.
  • Net margin of 10.8% and return on invested capital of 12.3% are modest for a stock priced at 14.1 times trailing earnings.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 5, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where SKWD's valuation models land
Price
$60.39
Model fair value
$56.63
Model range
$53.87 to $59.86
Fair value $56.63
Price $60.39
The price is above the whole model range.
Model
Fair value
Upside
P/E comparison
Residual income
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish69% buy · 13 covering analysts
● Strong buy 5● Buy 4● Hold 4● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
2 buys · 0 sells
Since Jul 10, 2026, 1 member
Average delay
32 days
From trade to public filing
Full trade list on ProDo politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-1.4%
1 month
+10.1%
3 months
-0.1%
6 months
+31.5%
YTD
+18.2%
1 year
+29.6%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
19 Oct 2026, 18:04 CESTRatingFairly valuedfirst publication$61.23
19 Oct 2026, 18:04 CESTFair value$56.63$55.74$61.23
11 Oct 2026, 00:00 CESTACCE price target$64.00first publication$58.32
10 Oct 2026, 00:00 CESTFair value$55.74$53.37$59.31
6 Oct 2026, 00:00 CESTFair value$53.37$53.98$55.01
29 Sept 2026, 00:00 CESTFair value$53.98$54.86$54.78
24 Sept 2026, 00:00 CESTFair value$54.86$55.46$55.91
16 Sept 2026, 00:00 CESTFair value$55.46$56.03$58.35
10 Sept 2026, 00:00 CESTFair value$56.03$58.92$56.53
25 Aug 2026, 00:00 CESTFair value$58.92$59.59$56.99

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full SKWD page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth92Value69Quality68Momentum97Total82
Valuation
Trailing P/E
14.0x
Forward P/E
11.5x
PEG
0.72
P/B
2.06x
EV / Revenue
1.5x
Book value/sh
$28.55
Enterprise value
$1.8B
Profitability
ROE
17.3%
FCF yield
14.59%
ROIC
12.3%
Health and risk
Debt / equity
0.12
Dividend yield
0.00%
Beta
0.35

Price

+30.3% · 1Y

Ask anything about SKWD

Answered from Skyward Specialty Insurance Group Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 40% of peers
low 5.1x14.0xhigh 19.1x
ROEbetter than 33% of peers
low -27%17%high 54%
Div yieldbetter than 33% of peers
low 0.0%0.0%high 1.2%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
SKWD Skyward Specialty Insurance Group Inc. Common Stock$60.39$577% above14.0x17.3%6882
HCI HCI Group Inc. Common Stock$206.68$30733% below8.9x35.0%9678
SLDE Slide Insurance Holdings Inc. Common Stock$27.75$5449% below6.9x53.9%10088
LMND Lemonade Inc. Common Stock$45.41----27.0%3936
PLMR Palomar Holdings Inc. Common stock$144.53$10439% above19.1x22.2%8075
Q.MX Qualitas ControladoraMXN 190.87MXN 11961% above17.8x17.2%5356
WTM White Mountains Insurance Group Ltd. Common Stock$2247.52$364038% below5.1x20.4%9175

Sector report card

Where SKWD ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Oct 8, 2026
    Skyward Specialty to Host Third Quarter 2026 Earnings Call Friday, November 6, 2026
  • GlobeNewswire•Sep 30, 2026
    Skyward Group Expands ibott’s Next-Generation Autonomous Vehicle Solutions Into U.S. Primary Market
  • GlobeNewswire•Sep 22, 2026
    Skyward Specialty Partners with SnapRefund to Set a New Standard for Claim Payments Using ClaimsSnap
4 more press releases · full archive on Investor+.INVESTOR
36 filings
August 2026
Aug 20
8-KCurrent reportPeriod 2026-08-20
View on SEC →
Aug 7
Form 4Insider transactionPeriod 2026-08-06
View on SEC →
Aug 7
10-QQuarterly reportPeriod 2026-06-30
View on SEC →
33 more filings + AI summaries on Investor+.INVESTOR